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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S234Results: Common among all impacted groups in comparison to CTRL
groups at every time point was the increased gene expression asso-
ciated with the IPA canonical pathway/functional category “Role of
Osteoblasts, osteoclasts and chondrocytes in Rheumatoid arthritis”
containing genes such as BMP2, BMP4, MMP13, FRZB, TNSF11, and ITGP3 .
The biological networks associated with impacts differed with impact
magnitude and time. After 24 hours, gene networks associated with
“Skeletal and Muscular system development and function, tissue
development, connective tissue disorders” (MATN3, MMP13, FGF18,
DMP1, BMP2, BMP4, COL9A1, TGFB3, etc.) were active after 17 MPa
impacts as compared to the biological network “Cellular development,
Cellular growth and proliferation, Skeletal and muscular system
development and function” (COL10A1, VCAN, WISP1, TGFB3, etc.) which
was differentially expressed after 36 MPa impacts. 36 MPa impacts also
changed the expression of genes in the “Granulocyte adhesion and
diapedesis” (CCL20, CXCL14, CXCR2, PECAM1, etc.) functional category
indicating a greater inﬂammatory response. Three days after impact,
both impact groups showed differential expression of genes in the “Cell
cycle, Cellular Assembly and organization, DNA replication, recombi-
nation and repair” group represented by genes such as CDK1, CENPE,
CENPF, MATN3, among others. Similar biological groups were also
identiﬁed 7 days after impact in the 17 MPa group with representative
genes such as BMP4, MMP13, OMD, COL10A1, COL1A1, and DMP1. In the
7-day, 36 MPa group, we observed markers such as IBSP, BAMBI, FGF7,
SP7, and POSTN.
Conclusions: While we observed differential expression of catabolic
genes such as MMP13, MMP3 and anabolic genes like COL2A1, COL1A1,
andMATN3 in most impact groups and time points, we found that each
condition was also characterized by the expression of speciﬁc sets of
genes. 24 hours after impact we noticed the expression of pro-
inﬂammatory genes (e.g. IL-6) following the high impact force. Three
days following impact, the top functional pathway identiﬁed by IPA in
both the 17MPa and the 36MPa groups contained genes involved in cell
cycle and DNA repair, suggesting the activation of a common reparatory
mechanism. At 7 days gene expression by cells in 17 and 36 MPa impact
samples diverged between chondrogenic/hypertrophic and osteogenic
functional groups. This difference may reﬂect a more advanced disease
state in the high impact group, or a different response altogether. Many
of the genes identiﬁed in this study were previously identiﬁed as
markers of OA, indicating that further validation and functional analy-
ses of novel loci identiﬁed here could lead to the development of new
PT-OA therapeutic candidates.
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Purpose: Previous studies have shown that high bone mineral density
(BMD) is associated with an increased risk of knee and hip osteo-
arthritis. We recently completed an analysis evaluating the association
of 56 established BMD loci (64 SNPs) for their association with radio-
graphic knee osteoarthritis (rKOA) and identiﬁed four genetic variants
associated with higher BMD that were also associated with higher odds
of rKOA. With this in mind we conducted genetic association analysis to
determine the relationship between these 56 BMD loci and radio-
graphic hip osteoarthritis (rHOA).
Methods: The current analysis was conducted on European-American
participants from the Osteoarthritis Initiative with genome wide gen-
otyping (Illumina 2.5 M array) and pelvis radiographs obtained at the
baseline and 48 month visits. Pelvis images were read for radiographic
features (IRFs) of hip OA using the OARSI atlas, and hips were classiﬁed
as deﬁnite rHOA (Croft grade2 or deﬁnite osteophytes or deﬁnite JSN),
possible rHOA (IRFs present but not deﬁnite, e.g. isolated grade 1
osteophyte or joint space narrowing) or normal. Cases had at least one
hip with deﬁnite rHOA at either time-point and hips replaced during
follow-up with an adjudicated diagnosis of OA or degenerative arthritis.
Controls had bilateral normal hips at baseline and, if radiographs were
available, at 48 month follow-up. Using these deﬁnitions we identiﬁed350 cases and 2294 controls with genotyping data for analysis. In two
sensitivity analyses we included subjects with possible RHOA as cases
and used as controls only those who had a 48-month pelvis ﬁlms.
Association analyses included adjustments for age, gender, BMI and
principal components to correct for ﬁne-scale population substructure.
Results:We identiﬁed one variant (rs7217932) near the SOX9 locus that
had a nominal association with rHOA (p ¼ 0.03, OR ¼ 1.20). The allele
associated with higher BMD was associated with higher odds of rHOA.
Of note, this variant was one of the few BMD loci associated with BMD
in the hip (femoral neck) but not the lumbar spine. The association did
not remain signiﬁcant when subjects with possible OAwere included as
cases (p ¼ 0.13, OR ¼ 1.10) but did when we required 48-month images
for controls (p ¼ 0.05 OR ¼ 1.18). None of the SNPs we identiﬁed from
our association analysis of rKOA were associated with rHOA (p > 0.05).
A BMD risk allele score based on 62 independent loci was not sig-
niﬁcantly associated with rHOA risk.
Conclusions: Despite a limited sample size we identiﬁed a nominal
association between a variant associated with femoral neck BMD and
rHOA, however this association does not remain signiﬁcant after
accounting for multiple testing. Replication analysis in additional
cohorts is needed to conﬁrm these ﬁndings, however the SOX9 locus
may play a role in osteoarthritis in addition to BMD at the hip.
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OSTEOARTHRITIC CHONDROCYTES
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Purpose: Microsomal prostaglandin E synthase-1 catalyzes the termi-
nal step in the biosynthesis of PGE2, which plays a critical role in the
pathophysiology of osteoarthritis. To investigate the role of histone H3
(H3K9) methylation in interleukin-1b (IL-1)-induced microsomal
prostaglandin E synthase-1 (mPGES-1) expression in human osteo-
arthritic (OA) chondrocytes.
Methods: Chondrocytes were stimulated with IL-1 and the expression
of mPGES-1mRNA was analyzed using real-time reverse transcriptase-
polymerase chain reaction. H3K9 methylation and the recruitment of
the histone demethylase LSD1 to the mPGES-1 promoter were eval-
uated using chromatin immunoprecipitation assays. The role of LSD1
was further evaluated using the the amino oxidase inhibitor tranylcy-
promine (a potent inhibitor of LSD1 activity).
Results: Treatment with IL-1 induced mPGES-1 expression in a time
dependent manner. The induction of mPGES-1 expression by IL-1 was
associated with H3K9 demethylation at the mPGES-1 promoter. These
changes were concomitant with the recruitment of the histone deme-
thylase LSD1. Treatment with tranylcypromine inhibited IL-1-induced
H3K9 demethylation as well as IL-1-induced mPGES-1 expression.
Conclusions: These results indicate that H3K9 demethylation by LSD1
contributes to IL-1-induced mPGES-1 expression and suggest that this
pathway could be a potential target for pharmacological intervention in
the treatment of OA and possibly other arthritic diseases.
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Purpose: The present study was initiated to investigate the interaction
of SNPs in Estrogen receptor-a (ESR-a), Calmodulin-1 (CALM-1) and
Growth differentiation factor-5 (GDF-5) gene with osteoarthritis knee
(KOA); correlation of these genetic variants with envoirmnental factor
such as living standards and occupation.
Methodology: In a case-control study, 300 cases with KOA and an equal
number of age matched healthy controls were included. Cases were
diagnosed using the American College of Rheumatology (ACR) guide-
lines of knee osteoarthritis (KOA). Blood was drawn for genomic DNA
isolation; polymerase chain reaction coupled restriction fragments
length polymorphism (PCR-RFLP), TaqMan assay were carried out to
